Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-57,892
Closed -$28.2M 101
2023
Q3
$28.2M Buy
+57,892
New +$27.2M 0.46% 67
2020
Q1
Sell
-78,007
Closed -$28.6M 95
2019
Q4
$28.6M Buy
78,007
+34,132
+78% +$10.8M 0.6% 54
2019
Q3
$11.2M Sell
43,875
-67,775
-61% -$19M 0.27% 75
2019
Q2
$29.6M Buy
+111,650
New +$28.3M 0.62% 58
2017
Q3
Sell
-44,668
Closed -$10.7M 129
2017
Q2
$10.7M Sell
44,668
-151,534
-77% -$34.3M 0.26% 78
2017
Q1
$40.4M Sell
196,202
-174,742
-47% -$36.1M 0.94% 44
2016
Q4
$75.7M Buy
370,944
+222,944
+151% +$42.5M 1.72% 15
2016
Q3
$26.2M Buy
+148,000
New +$25.7M 0.62% 64
2016
Q1
Sell
-115,100
Closed -$20.5M 95
2015
Q4
$20.5M Buy
+115,100
New +$20.2M 0.43% 67

Other funds holding HUM

Samlyn Capital's HUM Position: Q4 2023 in Review

Samlyn Capital sold out of Humana (HUM) in Q4 2023, closing a stake of 57,892 shares — an estimated $28.2M sold.

Samlyn Capital first reported a position in HUM in Q4 2015 and held it in 9 quarters. The position peaked at $75.7M in Q4 2016. 1,153 funds tracked by Wall St. Rank hold HUM as of Q4 2023.

  • Samlyn Capital reported no remaining Humana position as of Q4 2023 after selling out during the quarter.
  • Samlyn Capital sold 57,892 Humana shares in Q4 2023, an estimated $28.2M.
  • Samlyn Capital first reported a position in Humana in Q4 2015 and held it in 9 quarters.
  • Samlyn Capital's Humana position peaked at $75.7M in Q4 2016.
  • 1,153 funds tracked by Wall St. Rank held Humana as of Q4 2023.

Based on Samlyn Capital's 13F filing for Q4 2023, filed 14 Feb 2024.